Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes
NCT07458269
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
250
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
KAI-9531
DRUG:
Placebo
Sponsor
Kailera